Abstract
[18F]FDG PET-CT is a standard of care for initial staging of lymphomas, also helpful in the diagnosis of suspected neurolymphomas when MRI shows nerve enlargement.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Further Reading
Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH. Neurolymphomatosis. Neuro-Oncology. 2003 Apr;5(2):104–15.
Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro-Oncology. 2010;12(2):212–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Horowitz, T., Guedj, E. (2022). Case 30: Neurolymphomatosis. In: Varrone, A., Morbelli, S., Garibotto, V. (eds) Clinical Nuclear Medicine in Neurology. Springer, Cham. https://doi.org/10.1007/978-3-030-83598-9_30
Download citation
DOI: https://doi.org/10.1007/978-3-030-83598-9_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-83597-2
Online ISBN: 978-3-030-83598-9
eBook Packages: MedicineMedicine (R0)